Background illustration for clinical trials search

Paid Clinical Trials Princeton

Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: East Brunswick NJ, The Bronx NY, Stony Brook NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for
Cancer
Location: East Brunswick NJ, Lake Success NY, New Haven CT,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07540572

Phase 1, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: East Brunswick NJ, New York NY, Baltimore MD, Montreal,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase 1, Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for
Epidermal Growth Factor, Epidermal Growth Factor Receptor,
Location: East Brunswick NJ, Lake Success NY, Nashville TN,
Sponsor: EpiBiologics

Sex: All

Age: 18+

Code: NCT07462377

Phase 1, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: East Brunswick NJ, New York NY, Lake Success NY,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: East Brunswick NJ, New York NY, Fairfax VA, Boston MA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06303505

Phase 1, Phase 2, Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: East Brunswick NJ, Florham Park NJ, New York NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase 3, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: East Brunswick NJ, Hackensack NJ, Toronto, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: East Brunswick NJ, New Brunswick NJ, Flemington NJ,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase 3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: East Brunswick NJ, Brooklyn NY, New York NY, Mineola NY,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase 1, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: East Brunswick NJ, Allentown PA, Lake Success NY,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase 3, Recruiting

SLV-154 Treatment of Advanced Cancers

for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: East Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Solve Therapeutics

Sex: All

Age: 12+

Code: NCT06771219

Phase 1, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: East Brunswick NJ, Hackensack NJ, Teaneck NJ,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Somerset NJ, Horsham PA, Brooklyn NY, Sewell NJ,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: East Brunswick NJ, Morristown NJ, Shirley NY, Albany NY,
Sponsor: Corcept Therapeutics

Sex: All

Age: 18+

Code: NCT07259317

Phase 2, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: East Brunswick NJ, Summit NJ, Philadelphia PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

for
Metastatic Prostate Cancer
Location: East Brunswick NJ
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07529717

Phase 1, Phase 2, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: East Brunswick NJ, Commack NY, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase 2, Recruiting

Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study

for
Cognitive Impairment, Mild
Location: North Brunswick NJ, New Brunswick NJ
Sponsor: Bright Cloud International Corp

Sex: Female

Age: 20 - 65

Code: NCT04972019

Recruiting

Telerehabilitation Alzheimer's Disease Feasibility (TADF)

for
Alzheimer Disease, Healthy Aging
Location: North Brunswick NJ, New Brunswick NJ
Sponsor: Bright Cloud International Corp

Sex: All

Age: 65 - 70+

Code: NCT04732182

Recruiting